Just over a week ago, Judge Vivian Medinilla of Delaware Superior Court issued an order ruling that cases claiming Zantac (ranitidine ... and it was also sold in generic form by several other ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Glaxo’s patent for Zantac’s active ingredient, ranitidine, expired in 1997. That same year, pharmaceutical companies began ...